Use of 99mTc-mercaptoacetyltriglycine to evaluate renal function in horses.

This research studied the use of 99mTc-mercaptoacetyltriglycine (99mTc-MAG3), a type of radioactive tracer, in determining kidney function in horses. The results suggest that the radiopharmaceutical can effectively measure renal blood flow in horses, including those with kidney issues.

Objective of the Study

• The main objective of this study was to determine the efficacy of using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) as a way to measure renal function in horses. This particular compound is a radiopharmaceutical – a pharmaceutical drug that contains radioactive isotopes.

Methodology of the Research

• Researchers injected ten healthy horses intravenously with 99mTc-MAG3.
• They then measured the disappearance of radioactivity from the horses’ blood to determine how quickly the body was removing the compound.
• This allowed the team to calculate two values: the total body clearance (Cl(B)), which demonstrates the rate at which the compound is removed from the body, and the compound’s elimination half-life (t1/2(beta)), the time it takes for the body to eliminate half the substance.
• This process was repeated in two horses with compromised renal (kidney) function to compare the results.

Results of the Research

• The total body clearance rate was determined to be approximately 7.9 ml/kg/minute and the elimination half-life around 32.8 minutes.
• In the case of the horses with kidney issues, the radiopharmaceutical’s disappearance was also measured, though the specific values are not reported in the abstract.

Implications of the Research

• The results of this research suggest that 99mTc-MAG3 can be used as an effective and clinically applicable means to measure renal blood flow in horses.
• By extension, this radiopharmaceutical could potentially be leveraged for similar use in other animals or humans, though further research would be required to confirm this.
• This kind of research can help pave the way for more effective diagnosis and treatment options for renal diseases in horses, and potentially in other species as well.